简体
简体中文
繁體中文

Megan MGN 深 沪

等待开盘 11-18 09:30:00 美东时间

3.79

+0.260

+7.37%

华盛通华盛通
立即下载
  • 最 高3.92
  • 今 开3.615
  • 成交量 30.21万股
  • 最 低 3.61
  • 昨 收 3.53
  • 总市值 6152.45万
  • 52周最高 155.40
  • 市盈率 静 92.21
  • 换手率 0.00%
  • 52周最低 1.671
  • 委 比 77.02%
  • 总股本 1623.34万
  • 历史最高 258.90
  • 量 比 1.88
  • 振 幅 8.78%
  • 历史最低 1.95
  • 每 手 1
  • 风险率 31.94%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Campbellsville Now a ‘Gig-Ready’ Community from Kinetic’s Fiber-Optic Network Expansion

    Kinetic announced that Campbellsville, Ky., is now a "Gig-Ready Community," with over 75% of homes accessing its high-speed, next-generation internet. Over 7,500 locations benefit from improved connectivity, supporting work, education, streaming, and telehealth. Kinetic's fiber-optic network enhances digital infrastructure, driving economic growth and opportunities. Research shows fiber-connected communities experience 213% higher business growth...

    11-17 14:30

  • CNH’s Kurt Coffey Named 2027 Chair of Association of Equipment Manufacturers

    <p>Kurt Coffey, Vice President of North America CNH Agriculture Marketing, has been appointed as the 2027 Chair of the Association of Equipment Manufacturers (AEM). In this role, he will guide AEM's strategy and foster collaboration among equipment manufacturers to address industry challenges and opportunities. With extensive experience in agriculture and equipment manufacturing, Coffey emphasizes customer success and innovation. His leadership i...

    11-16 16:00

  • PIVOT-006 Phase 3 Registrational Trial Demonstrates Unprecedented Improvement in Recurrence-Free Survival (RFS) for Intermediate-Risk and High-Grade Ta Non-Muscle Invasive Bladder Cancer (NMIBC)

    CG Oncology announced positive results from the PIVOT-006 Phase 3 trial, showing cretostimogene reduced the risk of bladder cancer recurrence by 68% (HR 0.32, p<0.0001) with no Grade 3+ adverse events. The trial involved 367 patients with intermediate-risk and high-grade Ta NMIBC. The data will support a BLA submission in Q2 2027 and broaden the label for BCG-unresponsive NMIBC by March 2027. These findings highlight cretostimogene's potential as...

    11-16 13:00

  • Megan Holdings收跌2.94%,成交额4.87万美元

    11月12日,Megan Holdings(MGN)收跌2.94%,报3.3美元,成交额4.87万美元,市值5357.01万美元。 行情数据 • 开盘价:3....

    11-12 08:23

  • Archrock to Acquire HiVolt Energy Holdings, LLC

    Archrock acquires HiVolt Energy for up to $450 million, combining HiVolt's prime power microgrid platform with Archrock's natural gas compression capabilities. The deal aims to expand energy infrastructure offerings, enhance customer relationships, and generate recurring cash flows through long-term power agreements. The transaction is expected to boost Archrock's earnings and dividend capacity, with an upfront payment of $415 million and earnout...

    11-10 21:15

  • North Carolina Benefits from 15,800 New Kinetic Fiber Builds

    Kinetic announced a major broadband expansion in North Carolina, delivering multi-gig fiber internet to 15,800 additional homes in Q3 2026, with 162,000 new fiber locations across its 18-state footprint. This expansion supports remote work, gaming, streaming, agriculture, and telehealth. Kinetic’s fiber internet offers faster upload speeds, seamless 4K+ streaming, and low-latency gaming. The company also provides Wi-Fi 7, whole-home Wi-Fi setup, ...

    11-10 14:30

  • Verizon Makes the Holidays Simple with Our Best Deals and Rewards Just for Being a Customer

    Verizon offers holiday deals and exclusive rewards, including new device savings, home internet discounts, loyalty benefits, and once-in-a-lifetime experiences. Customers can get the latest smartphones with smartwatches and earbuds, save on activation fees, and enjoy gifts like TVs or gift cards. Verizon Loyalty members earn cash back and access weekly sweepstakes. Exclusive offers also include holiday-themed weeks with prizes like VIP experience...

    11-05 13:00

  • Entrada Therapeutics Reports Third Quarter 2026 Financial Results

    Entrada Therapeutics reported progress on its clinical trials for Duchenne muscular dystrophy, including completion of open-label dosing in ELEVATE-44-201 Cohort 1 and positive safety results in ELEVATE-45-201 Cohort 1. The company expects to receive data from these trials by year-end 2026 and early 2027, respectively. Cash reserves of $193 million are expected to support operations into Q4 2027.

    11-05 12:00

  • Megan Holdings收涨1.96%,成交额8.36万美元

    11月5日,Megan Holdings(MGN)收涨1.96%,报3.64美元,成交额8.36万美元,市值5908.93万美元。 行情数据 • 开盘价:3....

    11-05 08:21

  • Cartesian Therapeutics Announces New Employment Inducement Grant

    Cartesian Therapeutics granted a new employee an option to purchase 50,000 shares with an exercise price of $6.34. The option vests over four years, with 25% on November 2, 2027, and monthly installments until full vesting on November 2, 2030. The option has a ten-year term and was approved under the 2018 Employment Inducement Incentive Award Plan. The company specializes in cell therapy for autoimmune diseases, with its lead asset, Descartes-08,...

    11-03 12:00